Lv1
30 积分 2024-03-12 加入
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
12天前
已完结
Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis
16天前
已关闭
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
16天前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
17天前
已完结
Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent
21天前
已完结
Association between urinary C4d levels and disease progression in IgA nephropathy
21天前
已完结
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy
27天前
已完结
Analysis of IgA1 O-Glycans in IgA Nephropathy by Fluorophore-Assisted Carbohydrate Electrophoresis
28天前
已完结
Complement Inhibition Therapy in IgA Nephropathy: Total or Selective Inhibition?
1个月前
已关闭
Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies
1个月前
已完结
皖公网安备34019202002308
